Anti-empacho Liquid
NDC 53145-300
Product Information
Anti-empacho (sodium bicarbonate) is a OTC MONOGRAPH DRUG-approved product labeled by Menper Distributors, Inc.. This medication is typically used as a increased large intestinal motility [pe]. It is supplied as a liquid for oral administration. This product entry covers the primary NDC 53145-300 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 53145-300?
What are Active Ingredients of this product?
- SODIUM BICARBONATE 525 mg/15mL - A white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- SODIUM BICARBONATE (UNII: 8MDF5V39QO)
- SODIUM CATION (UNII: LYR4M0NH37) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALCOHOL (UNII: 3K9958V90M)
- IPECAC (UNII: 62I3C8233L)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- PEPPERMINT (UNII: V95R5KMY2B)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- RHUBARB (UNII: G280W4MW6E)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1305093 - sodium bicarbonate 525 MG in 15 mL Oral Solution
- RxCUI: 1305093 - sodium bicarbonate 0.417 MEQ/ML Oral Solution
- RxCUI: 1305093 - NaHCO3 0.417 MEQ/ML Oral Solution
- RxCUI: 1305093 - sodium bicarbonate 525 MG per 15 ML Oral Solution
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.